Several altered FGFR2 characteristics have been linked with breast tumorigenesis and have shown promising results in studies on breast cancer cell lines and tumors, like amplification and overexpression, mutations, alternative splicing and isoform switching [33]–[38], [62], [76], [79]–[83]. The gene discussed is FGFR2; the disease is breast cancer.